News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,349 Results
Type
Article (41339)
Company Profile (265)
Press Release (688729)
Multimedia
Podcasts (91)
Webinars (21)
Section
Business (204843)
Career Advice (2032)
Deals (35583)
Drug Delivery (128)
Drug Development (81509)
Employer Resources (173)
FDA (16505)
Job Trends (14979)
News (346812)
Policy (32750)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2593)
Accelerated approval (46)
Adcomms (26)
Allergies (171)
Alliances (49583)
ALS (210)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (441)
Approvals (16878)
Artificial intelligence (652)
Autoimmune disease (283)
Automation (54)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (175)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (745)
Cancer (5763)
Cardiovascular disease (466)
Career advice (1724)
Career pathing (42)
CAR-T (328)
CDC (56)
Celiac Disease (3)
Cell therapy (885)
Cervical cancer (47)
Clinical research (70753)
Collaboration (2034)
Company closure (5)
Compensation (1384)
Complete response letters (79)
COVID-19 (2740)
CRISPR (107)
C-suite (1106)
Cystic fibrosis (152)
Data (7788)
Decentralized trials (3)
Denatured (27)
Depression (159)
Dermatology (84)
Diabetes (585)
Diagnostics (6918)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (314)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (280)
Earnings (91962)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119401)
Executive appointments (1076)
FDA (20195)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1704)
Gene editing (232)
Generative AI (55)
Gene therapy (715)
GLP-1 (1050)
Government (4729)
Grass and pollen (6)
Guidances (408)
Healthcare (18990)
HIV (79)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (285)
Immuno-oncology (92)
Indications (189)
Infectious disease (3077)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (319)
IPO (16668)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (98)
Layoffs (561)
Leadership (39)
Legal (7953)
Liver cancer (99)
Longevity (32)
Lung cancer (757)
Lymphoma (428)
Machine learning (59)
Management (59)
Manufacturing (1032)
MASH (185)
Medical device (13920)
Medtech (14038)
Mergers & acquisitions (20153)
Metabolic disorders (1492)
mRNA (203)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (411)
Neuropsychiatric disorders (105)
Neuroscience (3282)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4530)
Now hiring (77)
Obesity (698)
Opinion (286)
Ovarian cancer (218)
Pain (250)
Pancreatic cancer (296)
Parkinson's disease (356)
Partnered (33)
Patents (592)
Patient recruitment (666)
Peanut (62)
People (59547)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22056)
Phase 2 (31170)
Phase 3 (23197)
Pipeline (8522)
Policy (314)
Postmarket research (2568)
Preclinical (9395)
Press Release (64)
Prostate cancer (294)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1066)
Real estate (5968)
Recruiting (70)
Regulatory (25359)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (286)
Series B (211)
Service/supplier (11)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3638)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1088)
Venture capital (107)
Weight loss (450)
Women's health (124)
Worklife (20)
Date
Today (175)
Last 7 days (924)
Last 30 days (3509)
Last 365 days (30266)
2026 (12078)
2025 (30170)
2024 (35211)
2023 (40072)
2022 (51173)
2021 (55708)
2020 (54082)
2019 (46537)
2018 (35016)
2017 (32107)
2016 (31479)
2015 (37553)
2014 (31320)
2013 (26356)
2012 (28575)
2011 (29263)
2010 (27328)
Location
Africa (741)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (39651)
Australia (6501)
California (13163)
Canada (3735)
China (1328)
Colorado (564)
Connecticut (571)
Delaware (401)
Europe (85801)
Florida (1966)
Georgia (421)
Hawaii (3)
Idaho (62)
Illinois (1045)
India (88)
Indiana (597)
Iowa (23)
Japan (530)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1580)
Massachusetts (9393)
Michigan (359)
Minnesota (712)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (84)
New Jersey (3460)
New Mexico (29)
New York (3436)
North Carolina (1669)
North Dakota (9)
Northern California (6595)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2648)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5189)
Tennessee (209)
Texas (2086)
United States (46427)
Utah (392)
Vermont (1)
Virginia (316)
Washington D.C. (80)
Washington State (1054)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
730,349 Results for "natera inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Natera Reports First Quarter 2026 Financial Results
May 8, 2026
·
12 min read
Press Releases
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
April 7, 2026
·
5 min read
Press Releases
Natera to Report its First Quarter Results on May 7, 2026
April 30, 2026
·
1 min read
Press Releases
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis
March 12, 2026
·
5 min read
Press Releases
Natera Submits Signatera™ CDx PMA to FDA
February 2, 2026
·
4 min read
Press Releases
Natera Reports Fourth Quarter and Full Year 2025 Financial Results
February 27, 2026
·
15 min read
Press Releases
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
April 14, 2026
·
4 min read
Press Releases
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026
·
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
·
1 min read
Press Releases
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
January 20, 2026
·
3 min read
1 of 73,035
Next
